Statement of Changes in Beneficial Ownership (4)

Date : 01/11/2019 @ 9:12PM
Source : Edgar (US Regulatory)
Stock : Cormedix (CRMD)
Quote : 1.71  -0.19 (-10.00%) @ 1:00AM

Statement of Changes in Beneficial Ownership (4)

FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Dillione Janet
2. Issuer Name and Ticker or Trading Symbol

CorMedix Inc. [ CRMD ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

C/O CORMEDIX INC., 400 CONNELL DRIVE, SUITE 5000
3. Date of Earliest Transaction (MM/DD/YYYY)

1/10/2019
(Street)

BERKELEY HEIGHTS, NJ 07922
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Restricted Stock Units   1/10/2019     A    12500   A   (1) 133909   D    
Restricted Stock Units   1/10/2019     A    5000   A   (1) 138909   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy Common Stock)   $1.66   1/10/2019     A      75000         (2) 1/10/2029   Common Stock   75000   $0   75000   D    
Phantom Stock     (3)                    (3)   (3) Common Stock   6637     6637   D    
Phantom Stock     (3)                    (3)   (3) Common Stock   13636     13636   D    
Phantom Stock     (3)                    (3)   (3) Common Stock   37500     37500   D    
Stock Option (Right to Buy Common Stock)   $0.57                      (4) 2/16/2028   Common Stock   40000     40000   D    
Phantom Stock     (3)                    (3)   (3) Common Stock   13392     13392   D    
Phantom Stock     (3)                    (3)   (3) Common Stock   15625     15625   D    
Phantom Stock     (3)                    (3)   (3) Common Stock   20833     20833   D    
Stock Option (Right to Buy Common Stock)   $2.24                      (5) 2/21/2027   Common Stock   40000     40000   D    
Phantom Stock     (3)                    (3)   (3) Common Stock   3472     3472   D    
Phantom Stock     (3)                    (3)   (3) Common Stock   4143     4143   D    
Stock Option (Right to Buy Common Stock)   $3.03                      (6) 8/11/2025   Common Stock   50000     50000   D    
Phantom Stock     (3)                    (3)   (3) Common Stock   1415     1415   D    
Stock Option (Right to Buy Common Stock)   $3.03                      (7) 2/21/2026   Common Stock   95000     95000   D    
Phantom Stock     (3)                    (3)   (3) Common Stock   3831     3831   D    
Phantom Stock     (3)                    (3)   (3) Common Stock   2767     2767   D    
Phantom Stock     (3)                    (3)   (3) Common Stock   4335     4335   D    
Phantom Stock     (3)                    (3)   (3) Common Stock   15306     15306   D    

Explanation of Responses:
(1)  These shares consist of restricted stock units granted on 01/10/2019. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board.
(2)  These options were granted on 01/10/2019. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
(3)  Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
(4)  These options were granted on 2/16/2018. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
(5)  These options were granted on 2/21/2017. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
(6)  These options were granted on 8/12/2015. The options vest as follows: 1/3 on 8/12/2015, 1/3 on 8/12/2016, and 1/3 on 8/12/2017.
(7)  These options were granted on 2/21/2016. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Dillione Janet
C/O CORMEDIX INC.
400 CONNELL DRIVE, SUITE 5000
BERKELEY HEIGHTS, NJ 07922
X



Signatures
/s/ Alexander M. Donaldson, by Power of Attorney 1/11/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Cormedix (AMEX:CRMD)
Historical Stock Chart

1 Year : From Jan 2018 to Jan 2019

Click Here for more Cormedix Charts.

Cormedix (AMEX:CRMD)
Intraday Stock Chart

Today : Sunday 20 January 2019

Click Here for more Cormedix Charts.

Latest CRMD Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.